According to a new technical market research report, Biochip
Markets: Microarrays and Lab-on-a-Chip (BIO049B) from BCC Research
(www.bccresearch.com), the world market for biochip products will be
worth some 1,937.9 million in 2007, a figure that is expected to
increase to $2115.6 million in 2008 and $3,840.7 million in 2013, a
compound annual growth rate (CAGR) of 12.7%.
The market is broken down into applications of DNA microarrays,
protein microarrays, emerging microarrays and lab-on-a-chip (LOAC)
technologies. Of these sectors, DNA microarrays have the largest share
of the market, worth an estimated $947.3 million in 2007 and expected to
reach $999 million in 2007 and $1,644.2 million by 2013, a CAGR of
10.8%. The overall growth rate of DNA microarrays is slowed by the
continuing maturation of the gene expression market, which represents a
large segment of DNA microarrays. However, newer applications for DNA
microarrays are emerging, including SNP genotyping, and are providing a
significant growth impetus to this market segment. LOACs have the second
largest market share, expected to reach nearly $691.3 million in 2008
and $1,245.4 million by 2013, a CAGR of 12.5%. DNA microarrays and LOACs
are projected to continue to dominate the biochip market through 2013.
Protein microarrays are an emerging market opportunity as a result
of continuing advances in proteomics to understand gene function and
diseases. Tissue microarrays represent a growth opportunity in the
emerging microarray segment.
Report published September 2007 at a print price of $4250 by BCC
Research (www.bccresearch.com), 40 Washington Street, Suite 110,
Wellesley, MA; Telephone: 866/285-7215,
COPYRIGHT 2008 Worldwide
Videotex Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.